211 related articles for article (PubMed ID: 7636869)
21. Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H [1]b enzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907).
van Vliet LA; Rodenhuis N; Dijkstra D; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Sundell S; Lundmark M
J Med Chem; 2000 Jul; 43(15):2871-82. PubMed ID: 10956195
[TBL] [Abstract][Full Text] [Related]
22. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
[TBL] [Abstract][Full Text] [Related]
23. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB
Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811
[TBL] [Abstract][Full Text] [Related]
25. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
K B; V T; N P; M M; N M; F A
Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
[TBL] [Abstract][Full Text] [Related]
26. D
Mailman RB; Yang Y; Huang X
Eur J Pharmacol; 2021 Feb; 892():173760. PubMed ID: 33279520
[TBL] [Abstract][Full Text] [Related]
27. trans-2,6-,3,6- and 4,6-diaza-5,6,6a,7,8,12b-hexahydro-benzo[c]phenanthrene-10,11- diols as dopamine agonists.
Gu YG; Bayburt EK; Michaelides MR; Lin CW; Shiosaki K
Bioorg Med Chem Lett; 1999 May; 9(10):1341-6. PubMed ID: 10360732
[TBL] [Abstract][Full Text] [Related]
28. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE
Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913
[TBL] [Abstract][Full Text] [Related]
29. Functional selectivity of dopamine receptor agonists. II. Actions of dihydrexidine in D2L receptor-transfected MN9D cells and pituitary lactotrophs.
Kilts JD; Connery HS; Arrington EG; Lewis MM; Lawler CP; Oxford GS; O'Malley KL; Todd RD; Blake BL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 2002 Jun; 301(3):1179-89. PubMed ID: 12023553
[TBL] [Abstract][Full Text] [Related]
30. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
31. Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
Darney KJ; Lewis MH; Brewster WK; Nichols DE; Mailman RB
Neuropsychopharmacology; 1991 Nov; 5(3):187-95. PubMed ID: 1684499
[TBL] [Abstract][Full Text] [Related]
32. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
[TBL] [Abstract][Full Text] [Related]
33. Substituted hexahydrobenzo[f]thieno[c]quinolines as dopamine D1-selective agonists: synthesis and biological evaluation in vitro and in vivo.
Michaelides MR; Hong Y; DiDomenico S; Bayburt EK; Asin KE; Britton DR; Lin CW; Shiosaki K
J Med Chem; 1997 May; 40(11):1585-99. PubMed ID: 9171869
[TBL] [Abstract][Full Text] [Related]
34. The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.
Schechter MD
Psychopharmacology (Berl); 1995 May; 119(1):79-84. PubMed ID: 7675953
[TBL] [Abstract][Full Text] [Related]
35. Fluorescent and biotin probes for dopamine receptors: D1 and D2 receptor affinity and selectivity.
Madras BK; Canfield DR; Pfaelzer C; Vittimberga FJ; Difiglia M; Aronin N; Bakthavachalam V; Baindur N; Neumeyer JL
Mol Pharmacol; 1990 Jun; 37(6):833-9. PubMed ID: 2141665
[TBL] [Abstract][Full Text] [Related]
36. Dihydrexidine, a novel selective high potency full dopamine D-1 receptor agonist.
Lovenberg TW; Brewster WK; Mottola DM; Lee RC; Riggs RM; Nichols DE; Lewis MH; Mailman RB
Eur J Pharmacol; 1989 Jul; 166(1):111-3. PubMed ID: 2572425
[No Abstract] [Full Text] [Related]
37. Multiple fluorescent ligands for dopamine receptors. I. Pharmacological characterization and receptor selectivity.
Barton AC; Kang HC; Rinaudo MS; Monsma FJ; Stewart-Fram RM; Macinko JA; Haugland RP; Ariano MA; Sibley DR
Brain Res; 1991 May; 547(2):199-207. PubMed ID: 1679366
[TBL] [Abstract][Full Text] [Related]
38. Probing the steric space at the floor of the D1 dopamine receptor orthosteric binding domain: 7α-, 7β-, 8α-, and 8β-methyl substituted dihydrexidine analogues.
Cueva JP; Gallardo-Godoy A; Juncosa JI; Vidi PA; Lill MA; Watts VJ; Nichols DE
J Med Chem; 2011 Aug; 54(15):5508-21. PubMed ID: 21714510
[TBL] [Abstract][Full Text] [Related]
39. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
40. Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
Johnson BJ; Peacock V; Schneider JS
Pharmacol Biochem Behav; 1995 Aug; 51(4):617-22. PubMed ID: 7675833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
